BIOLOGICAL PREPARATIONS GROUP LIMITED

Accounts Submitted 6 Jun 2025

Confirmation Statement Submitted 25 Sept 2025

Net assets £-10.67M £1.59M 2024 year on year

Total assets £5.54M £865.72K 2024 year on year

Total Liabilities £16.21M £724.57K 2024 year on year

Charges 3

2 outstanding 1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Unit 12 A-C Pantglas Industrial Estate Bedwas Caerphilly CF83 8DR United Kingdom

Telephone

0292 067 4094

enquiries@biologicalpreparations.com

Website

biologicalpreparations.com

Credit Report

Discover BIOLOGICAL PREPARATIONS GROUP LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£14.66k

Increased by £200.00 (+1%)

Net Assets

-£10.67M

Decreased by £1.59M (-18%)

Total Liabilities

£16.21M

Increased by £724.57k (+5%)

Turnover

£14.88M

Increased by £773.38k (+5%)

Employees

102

Increased by 5 (+5%)

Debt Ratio

293%

Increased by 51 (+21%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

5 active 9 resigned

Show resigned officers

						Status
Colin Brian Davis	Director	Northern Irish	England	42	30 May 2023	Active
James Stuart Patterson	Director	British	Wales	50	13 Mar 2015	Active
Leslie Stuart Patterson	Director	British	England	78	13 Mar 2015	Active
Mercia Fund Management (nominees) Limited	Corporate-director	United Kingdom	Unknown	—	17 Sept 2025	Active
Paul Mccluskey	Director	British	England	62	1 Jul 2021	Active

Shareholders

Shareholders (17)


Peter Graham	3.2%	76,465	Ordinary	5 Oct 2022
Sharon Wilson	1.5%	35,291	Ordinary	5 Oct 2022
Paul Mccluskey	1.4%	34,606	Ordinary	5 Oct 2022

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Mercia Fund Management Limited

United Kingdom

Active

Notified 1 Apr 2022

Nature of Control

Significant Influence Or Control

Northern Venture Trust Plc

United Kingdom

Active

Notified 2 Aug 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent

Nvmequity Llp

Ceased 1 Apr 2022

Ceased

See All Controllers

Group Structure

MERCIA FUND MANAGEMENT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

NORTHERN VENTURE TRUST PLC united kingdom

MERCIA ASSET MANAGEMENT PLC united kingdom

BIOLOGICAL PREPARATIONS GROUP LIMITED Current Company

BIOLOGICAL PREPARATIONS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

CLEVELAND BIOTECH (HOLDINGS) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

2 outstanding 1 satisfied

Documents

Company Filings

Date	Category	Description	Document
25 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-09-24 with no updates	View(3 pages)
25 Sept 2025	Officers	Appointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17	View(2 pages)
25 Sept 2025	Officers	Termination of Peter Michael Dines as director on 2025-09-17	View(1 page)
6 Jun 2025	Accounts	Annual accounts made up to 2024-12-31	View(45 pages)
25 Sept 2024	Confirmation Statement	Confirmation statement made on 2024-09-24 with no updates	View(3 pages)